StockWatch
·
Q2 FY-2027 RESULTS · MANALIPETC

Manali Petro Q2 FY27: Consol PAT Jumps 250% YoY to ₹63.5 Cr as OPM Expands to ~20%

PAT +249.86% YoY · revenue +59.48% · margins expanding

Q2 FY27 resultsMANALIPETCMANALI PETROCHEMICAL LTD.06 Nov 2026 · 3 min read
Revenue

₹395.57 Cr

+59.48% YoY

PAT (consolidated)

₹63.5 Cr

+249.86% YoY

Net margin

15.32%

+8.4pp YoY

EPS

₹3.69

Manali Petrochemicals' consolidated Q2 FY27 (quarter ended 30-Sep-26) revenue rose 59.5% YoY to ₹395.57 Cr and PAT rose 249.9% YoY to ₹63.50 Cr — adjusted to ~+234% after excluding a ₹0.98 Cr one-off exceptional expense booked in the year-ago quarter — with OPM expanding to ~20.0% from 7.79% and NPM to 15.32% from 6.96%. No analyst consensus or management guidance exists for this quarter (confirmed via search: no formal Street estimates or company outlook on record for Manali Petrochemicals), so the print cannot be benchmarked against external expectations and stands on its own against last year's base.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹395.57 Cr+44%+59.5%
Expenses₹329.07 Cr+61.3%+37.7%
PAT₹63.5 Cr-1.33%+249.86%
Net margin15.32%-7pp+8.4pp
EPS₹3.69-1.3%+248.1%

Sequentially, PAT was effectively flat (-1.3% QoQ from ₹64.36 Cr) even as revenue grew 44.0% QoQ, because OPM compressed from Q1 FY27's 30.14% to ~20.0% — propylene glycol/propylene oxide economics are spread-driven rather than volume-driven, so a bigger topline did not carry through to the bottom line this quarter. Cost of materials consumed rose to ₹217.46 Cr (55% of revenue) from ₹168.25 Cr in Q1, outpacing the 44% revenue growth and compressing the spread.

₹
60.9969.6778.3587.0495.7273.9808-0308-2509-1710-1211-0411-06Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹73.98, down 18.2% over the past month of trading.

₹ Cr
025.5551.0976.6414.34Q1 FY26rev ₹235 Cr18.15Q2 FY26rev ₹248 Cr68.43Q3 FY26rev ₹247 Cr29.03Q4 FY26rev ₹293 Cr64.36Q1 FY27rev ₹275 Cr63.5Q2 FY27rev ₹396 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

NPM at 15.32% vs 6.96% YoY, down from 22.31% QoQ.

EPS ₹3.69 (consolidated, not annualised) vs ₹1.06 YoY and ₹3.74 QoQ.

Consolidated figures (primary) run ~₹10 Cr ahead of standalone PAT of ₹53.47 Cr; the gap is explained almost entirely by the two overseas subsidiaries under AMCHEM Speciality Chemicals (Singapore), which contributed a combined ₹9.78 Cr PAT this quarter per the auditors' report. Note the comparable base a year ago still included Notedome Limited (UK) and Notedome Europe GmbH, divested in November 2025, so the consolidated perimeter itself has changed YoY. This quarter's disclosed developments were administrative (results approved 6-Nov, insider-trading window closure, a September exchange clarification on a price surge) with no operational catalysts; the open items remain the pending Tamil Nadu leasehold-land renewal (lease expired June 2017) and an ₹11.80 Cr Cyclone Michaung insurance claim still carried as a receivable, both repeated as emphasis-of-matter by the auditors. No management press release was available to cross-check the company's own framing of the quarter.

  • W1

    Whether OPM holds near 20% or reverts toward the 7-10% band seen before Q1 FY27, since this is a spread- not volume-driven business.

  • W2

    Resolution of the Tamil Nadu leasehold-land renewal (expired June 2017, still pending) and the ₹11.80 Cr Cyclone Michaung insurance claim carried as a receivable.

  • W3

    No formal management guidance exists — next quarter's print is the only confirmation of whether the margin expansion is structural or a spread-cycle peak.

Informational and educational content only. Not investment advice.